XLS-Medical is a leading brand of scientifically-backed weight management products owned by Omega Pharma, a subsidiary of the multinational pharmaceutical company Perrigo. The brand specializes in naturally derived weight loss aids classified as Class IIa and Class IIb medical devices, which are tested for safety and efficacy under European regulations.
Core Product Range and Mechanisms
XLS-Medical products primarily work by reducing the absorption of calories from macronutrients through patented, plant-based complexes.
XLS-Medical Fat Binder (Original):
Contains Litramine, a patented fiber complex derived from dried cactus leaves (prickly pear). It binds with dietary fats to form a large fat-fiber complex that is too big for the small intestine to absorb, allowing it to pass naturally through the body.
XLS-Medical Max Strength:
Features Clavitanol, a plant-based complex that blocks the activity of specific digestive enzymes. This reduces the breakdown and absorption of complex carbohydrates, simple sugars, and fats. It is marketed as being up to 33% more effective than the original Fat Binder.
XLS-Medical PRO-7:
The brand’s most advanced product, containing Okranol, an exclusive natural fiber complex. It is clinically proven to help users lose up to 5 times more weight than dieting alone and focuses on seven benefits, including reducing body fat and improving gut microflora diversity.
XLS-Medical Nutrition:
A sub-brand offering meal replacement options like shakes to complement the primary medical device tablets.
Key Company Features
Scientifically Proven Efficacy:
Many products are marketed with clinical study results, such as the ability to lose up to 3x more weight with the Fat Binder or up to 5x more weight with PRO-7 compared to dieting alone.
Safety Profile:
Products are generally well-tolerated and derived from organic plant sources. They do not contain added artificial colorings, flavors, salt, or preservatives and are often suitable for vegetarians and vegans.
Target Audience:
Recommended for adults over 18 with a Body Mass Index (BMI) above 18.5, specifically targeting those who are overweight (BMI 25-30) or obese.
Lifestyle Integration:
The brand emphasizes that its products should be used as part of an overall weight management plan that includes a balanced diet and regular physical activity.
Manufacturer and Distribution
XLS-Medical is headquartered under Omega Pharma Ltd. in London and operates extensively across Europe, with a significant presence in the UK and Belgium. As part of the Perrigo Company plc network, it benefits from large-scale pharmaceutical manufacturing and global distribution standards.